PARP1 and ovarian neoplasm: Confirming these findings, in a PARP inhibitor-resistant ovarian tumor, a mutated PARP1 was found that does not alter the mobilization of the PARP1 enzyme toward the damaged locus of DNA but prevents the trapping of PARP1 (Pettitt et al., 2018).